Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Generic Edoxaban 60 mg vs Lixiana in Healthy Thai Volunteers (Fasting)
TCTR20230826003Phase 1Completed
- Sponsor
- Unison Laboratories
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of edoxaban (2 arms), sponsored by Unison Laboratories. Primary endpoint: Bioequivalence of generic edoxaban vs Lixiana (Cmax, AUC). Started Apr 2024; status: completed.
02
Drugs
edoxaban
Beyond the preview
Go deeper on TCTR20230826003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230826003.